Roth MKM analyst Jason Wittes initiated coverage of Monogram Orthopaedics (MGRM) with a Buy rating and $4 price target The firm believes Monogram’s mBos robotics platform simplifies surgery with autonomous cutting. It sees the company excelling in bone preparation and personalization, challenging Stryker’s dominance in robotics.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks